4篇
您的检索式：作者名="Chihiro Hayashi"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Yucasin is a potent inhibitor of YUCCA , a key enzyme in auxin biosynthesis显示文摘 | Takeshi Nishimura Ken‐ichiro Hayashi Hiromi Suzuki Atsuko Gyohda Chihiro Takaoka Yusuke Sakaguchi Sachiko Matsumoto Hiroyuki Kasahara Tatsuya Sakai Jun‐ichi Kato Yuji Kamiya Tomokazu Koshiba | 2014 | Plant J2014，，3： | 1 |
| 2 | 9.轧管工艺的发展显示文摘我想借此机会,就上述题目,着重介绍一下近十年来我们所取得的最新技术发展成果及其在生产实践中的运用情况。尤其引以自豪的是,我们对住友超级辊式穿孔机与自动轧管机中管端减薄液压压下控制系统等这一类的研制成果。 | Chihiro Hayashi 邓叶汀 | 1989 | 钢管1989，18，2： | 1 |
| 3 | Influences of piercing ratio, expansion ratio, feed, cross and skew angles on available piercing size range in rotary piercing process显示文摘 | Chihiro Hayashi Tomio Yamakawa | 1998 | ISIJ International1998，38，11： | 1 |
| 4 | Surgery for pancreatic tumors in the midst of COVID-19 pandemic显示文摘The spread of the new coronavirus(COVID-19)infection in 2020 has had a significant impact on the treatment of cancer worldwide.During the COVID-19 pandemic,the biggest challenge for pancreatic surgeons is the difficulty in providing oncological care.In this review article,from the standpoint of surgeons,we explain the concept of triaging of patients with pancreatic tumors under the COVID-19 pandemic,and the actual impact of COVID-19 on the treatment of patients with pancreatic tumors.The most vital points in selecting the best therapeutic approach for patients with pancreatic tumors during this pandemic are(1)Oncologists need to tailor the treatment plan based on the COVID-19 phase,tumor malignant potential,and patients’comorbidities;and(2)Optimal treatment for pancreatic cancer should be planned according to the condition of each patient and tumor resectability based on national comprehensive cancer network resectability criteria.To choose the best therapeutic approach for patients with pancreatic tumors during this pandemic,we need to tailor the treatment plan based on elective surgery acuity scale(ESAS).Newly established ESAS for pancreatic tumor and flowchart indicating the treatment strategy of pancreatic cancer,are feasible to overcome this situation. | Hiroyuki Kato Yukio Asano Satoshi Arakawa Masahiro Ito Norihiko Kawabe Masahiro Shimura Chihiro Hayashi Takayuki Ochi Hironobu Yasuoka Takahiko Higashiguchi Yuka Kondo Hidetoshi Nagata Akihiko Horiguchi | 2021 | World Journal of Clinical Cases2021，9，18： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员